Piramal Pharma Ltd.

•

piramalpharma.comBSE: 543635NSE: PPLPHARMA

Market Cap₹ 28,125 Cr.

Current Price

High / Low₹ 232 / 132

Stock P/E—

Book Value₹ 60

Price to Book2.24

Dividend Yield0.00 %

ROCE1.2 %

ROE-4.0 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company generates healthy free cash flow

CONS

Company is loss-making at the operating / net level
Recent results are weak - TTM profit is down 373.7% versus prior year
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -16.36x)
Company has a low return on equity of -0.9% over last 3 years
Company has a low return on capital employed of 4.3%
Interest coverage is weak at 0.5x - earnings barely cover interest

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY PHARMA NIFTY TOTAL MKT NIFTY SMLCAP 50 NIFTY 500 NIFTY SMLCAP 250

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	PPLPHARMA	211.25	40.16	28124.73	0.00	-69.39	15.07	2269.92	17.39	1.24	9.46

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,749	1,911	1,959	2,552	1,951	2,242	2,204	2,754	1,934	2,044	2,140	2,752	2,270
	1,617	1,646	1,690	2,022	1,747	1,900	1,866	2,193	1,827	1,885	1,944	2,291	2,386
Operating Profit	132	266	268	530	204	342	338	561	107	159	196	461	-116
OPM %	7.57%	13.90%	13.70%	20.76%	10.48%	15.24%	15.32%	20.37%	5.52%	7.76%	9.15%	16.74%	-5.13%
	38	49	29	-4	20	61	12	42	79	66	2	-130	89
Interest	119	110	106	114	107	108	103	104	86	82	89	83	88
Depreciation	174	185	186	196	185	192	197	243	197	203	213	218	224
Profit before Tax	-122	20	5	215	-67	103	50	257	-98	-61	-104	29	-7
Tax %	7.02%	168.90%	170.98%	58.58%	-64.55%	94.82%	126.87%	46.50%	-2.75%	-86.99%	-40.66%	176.11%	-830.16%
Net Profit	0	0	0	0	-89	226	37	154	-82	-99	-136	-88	-69
	-0.81	0.04	0.08	0.77	-0.67	0.17	0.03	1.16	-0.62	-0.75	-1.03	-0.07	-0.52

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	6,315	6,559	7,082	8,171	9,151	8,869	9,205
	4,887	5,609	6,453	7,001	7,733	7,977	8,507
Operating Profit	1,428	950	628	1,171	1,418	892	698
OPM %	22.61%	14.48%	8.87%	14.32%	15.49%	10.06%	7.59%
	182	261	218	138	162	46	27
Interest	163	198	344	448	422	341	343
Depreciation	545	586	677	741	816	831	858
Profit before Tax	949	485	-120	179	415	-176	-143
Tax %	12.01%	22.48%	-55.19%	90.06%	78.02%	-85.13%	-146.12%
Net Profit	835	376	-186	18	91	-326	-352
EPS	13.30	3.19	-1.54	0.13	0.69	-2.46	—
Dividend Payout %	0.00%	0.00%	0.00%	81.66%	20.35%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 7%
3 Years:: 8%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: 28%
1 Year:: 6%

RETURN ON EQUITY

10 Years:: —
5 Years:: 0%
3 Years:: -1%
Last Year:: -4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	995	1,186	1,193	1,323	1,324	1,327
	4,610	5,511	5,580	6,561	6,739	6,763
	2,936	3,521	4,968	3,941	4,484	5,339
Trade Payables	918	1,026	1,193	1,538	1,534	2,479
	1,297	1,473	1,502	1,562	1,288	1,658
Total Liabilities	10,756	12,717	14,437	14,925	15,369	17,567
	6,105	6,879	7,469	7,990	8,133	8,684
Capital Work in Progress	400	673	853	566	489	799
	123	267	639	385	291	437
	1,232	1,389	1,681	2,176	2,313	3,064
	0	0	0	2,134	2,350	2,158
Cash & Bank	406	329	308	483	501	1,224
	2,491	3,180	3,487	1,192	1,292	1,201
Total Assets	10,756	12,717	14,437	14,925	15,369	17,567

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	742	936	673	1,005	892	1,653
Cash from Investing	-4,480	-1,812	-1,339	-434	-477	-826
Cash from Financing	3,977	794	818	-422	-441	-39
	94	-251	-37	148	-26	788

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	34.95	34.95	34.95	34.95	34.86	34.86	34.86	34.86	34.80
	31.41	31.73	31.68	31.49	30.86	30.27	29.66	30.17	12.51
	12.95	13.80	14.09	14.78	14.25	14.89	15.69	15.61	14.57
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	20.69	19.52	19.27	18.78	20.03	19.98	19.79	19.36	38.11

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-08

Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-08 - Intimation of Schedule of Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-09-03

General Updates

2026-09-03 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating

2026-08-24

Updates

2026-08-24 - Sustainability Report of Piramal Pharma Limited ( the Company ) for thefinancial year 2025-26-26

2026-08-18

Acquisition

2026-08-18 - Piramal Pharma Limited has informed the Exchange about Acquisition

2026-08-10

Updates

2026-08-10 - Piramal Pharma Limited has informed the Exchange regarding 'Exercise of call option for acquisition of additional equity stake in Yapan Bio PrivateLimited'.

2026-08-10

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-10 - Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-08-03

Updates

2026-08-03 - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Resumption of operations at Company s facilities located at Ahmedabad, Gujarat

2026-07-31

Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-31 - Piramal Pharma Limited has informed the Exchange about Transcript

2026-07-30

Shareholders meeting

2026-07-30 - Proceedings and Voting Results of the 6th Annual General Meeting of the Company

News

Recent coverage and analyst commentary for PPLPHARMA

Loading news…

🤖

AI Stock Analyst

Piramal Pharma Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

PPLPHARMA

211.25

40.16

28124.73

0.00

-69.39

15.07

2269.92

17.39

1.24

9.46

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

1,749

1,911

1,959

2,552

1,951

2,242

2,204

2,754

1,934

2,044

2,140

2,752

2,270

1,617

1,646

1,690

2,022

1,747

1,900

1,866

2,193

1,827

1,885

1,944

2,291

2,386

Operating Profit

132

266

268

530

204

342

338

561

107

159

196

461

-116

OPM %

7.57%

13.90%

13.70%

20.76%

10.48%

15.24%

15.32%

20.37%

5.52%

7.76%

9.15%

16.74%

-5.13%

-4

-130

Interest

119

110

106

114

107

108

103

104

Depreciation

174

185

186

196

185

192

197

243

197

203

213

218

224

Profit before Tax

-122

215

-67

103

257

-98

-61

-104

-7

Tax %

7.02%

168.90%

170.98%

58.58%

-64.55%

94.82%

126.87%

46.50%

-2.75%

-86.99%

-40.66%

176.11%

-830.16%

Net Profit

-89

226

154

-82

-99

-136

-88

-69

-0.81

0.04

0.08

0.77

-0.67

0.17

0.03

1.16

-0.62

-0.75

-1.03

-0.07

-0.52

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

6,315

6,559

7,082

8,171

9,151

8,869

9,205

4,887

5,609

6,453

7,001

7,733

7,977

8,507

Operating Profit

1,428

950

628

1,171

1,418

892

698

OPM %

22.61%

14.48%

8.87%

14.32%

15.49%

10.06%

7.59%

182

261

218

138

162

Interest

163

198

344

448

422

341

343

Depreciation

545

586

677

741

816

831

858

Profit before Tax

949

485

-120

179

415

-176

-143

Tax %

12.01%

22.48%

-55.19%

90.06%

78.02%

-85.13%

-146.12%

Net Profit

835

376

-186

-326

-352

EPS

13.30

3.19

-1.54

0.13

0.69

-2.46

—

Dividend Payout %

0.00%

81.66%

20.35%

0.00%

—

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

995

1,186

1,193

1,323

1,324

1,327

4,610

5,511

5,580

6,561

6,739

6,763

2,936

3,521

4,968

3,941

4,484

5,339

Trade Payables

918

1,026

1,193

1,538

1,534

2,479

1,297

1,473

1,502

1,562

1,288

1,658

Total Liabilities

10,756

12,717

14,437

14,925

15,369

17,567

6,105

6,879

7,469

7,990

8,133

8,684

Capital Work in Progress

400

673

853

566

489

799

123

267

639

385

291

437

1,232

1,389

1,681

2,176

2,313

3,064

2,134

2,350

2,158

Cash & Bank

406

329

308

483

501

1,224

2,491

3,180

3,487

1,192

1,292

1,201

Total Assets

10,756

12,717

14,437

14,925

15,369

17,567

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

742

936

673

1,005

892

1,653

Cash from Investing

-4,480

-1,812

-1,339

-434

-477

-826

Cash from Financing

3,977

794

818

-422

-441

-39

-251

-37

148

-26

788

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

34.95

34.86

34.80

31.41

31.73

31.68

31.49

30.86

30.27

29.66

30.17

12.51

12.95

13.80

14.09

14.78

14.25

14.89

15.69

15.61

14.57

Government

0.00

20.69

19.52

19.27

18.78

20.03

19.98

19.79

19.36

38.11

Piramal Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Piramal Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI